Nutrition, Metabolic & Cognitive Neuroscience · · 21 min read · By

Dihexa for Artificial Sweetener Brain Fog: Aspartame, Erythritol, Diet Soda & the 2026 UK Review

Dihexa for artificial sweetener brain fog - 2026 UK evidence review illustration showing aspartame, erythritol, a diet soda can and a brain

Diet drinks and “zero-sugar” foods are sold as the guilt-free choice — so it unsettled a lot of people when, in October 2025, a study in Neurology linked high artificial-sweetener intake to faster cognitive decline. Headlines about “aspartame brain fog” and “diet soda dementia” followed within hours. At almost the same time, a University of Colorado laboratory reported that the popular “natural” sweetener erythritol harmed human brain blood-vessel cells. And there is a distinctly British twist: the sugar tax has quietly pushed the nation to swallow more sweeteners than ever. So do artificial sweeteners really cause brain fog, how much of this is reverse causation, and where — if anywhere — does a synaptogenic peptide like Dihexa fit? This 2026 UK review separates the genuine signals from the scare, and explains why the honest fix is the cheapest thing on the shelf.

Not medical advice. Dihexa (PNB-0408) is an unscheduled research chemical, not an approved treatment for brain fog or anything else. Artificial sweeteners are regulated food additives judged safe at normal intakes by UK and international agencies; nothing here is a claim that they are dangerous at ordinary doses, nor a recommendation to take any product. This page is general information, not medical advice. If you have persistent brain fog, the right first step is a proper assessment with your GP to rule out treatable causes. Read the full legal disclaimer.

Key Findings: Artificial Sweeteners & Brain Fog vs Dihexa

  • The 2025 headline study: An October 2025 Neurology study of 12,772 adults found the highest sweetener consumers declined about 62% faster on memory and thinking — but it shows association, not causation.
  • Reverse causation is the elephant in the room: People with diabetes or trying to cut sugar consume more sweeteners — and the effect was strongest in diabetes, exactly where you would expect confounding.
  • A plausible brain mechanism exists: High-dose animal work links aspartame to microglial neuroinflammation and suppressed BDNF/TrkB signalling via methanol and phenylalanine — but this is rodent, high-dose biology.
  • The erythritol vascular flag: A 2025 University of Colorado study found one drink’s worth of erythritol raised reactive oxygen species ~75%, cut nitric oxide and blunted clot-busting in brain vessel cells — a possible stroke concern.
  • The regulators’ verdict: The WHO/IARC call aspartame a possible carcinogen (Group 2B) but kept the safe intake at 40 mg/kg/day — dozens of cans daily.
  • The UK sugar-tax irony: The Soft Drinks Industry Levy reformulated 89% of fizzy drinks below the sugar threshold — by swapping sugar for sweeteners.
  • Where Dihexa stands: No completed human trial for brain fog; a pre-clinical-only HGF/c-Met case; a pro-proliferative c-Met concern; and a closest clinical relative, fosgonimeton, that failed its Alzheimer’s Phase 3.
  • Bottom line: If sweeteners are fogging you, pour the drink away and switch to water — a free test that beats any peptide. Reaching for a c-Met-activating research chemical to counter a possible-carcinogen sweetener is the wrong answer twice over.

The Sugar-Tax Paradox: Why Britain Now Swallows More Sweeteners

To understand the 2025 sweetener scare, start with a policy success that had an unintended side-effect. The UK’s Soft Drinks Industry Levy — the “sugar tax” — came into force in 2018 and worked spectacularly on its own terms: by Treasury figures, 89% of fizzy drinks sold in the UK were reformulated to fall below the taxable sugar threshold, and sugar levels in affected products fell by almost half between 2015 and 2024. In 2025 the government confirmed it would go further, lowering the threshold that triggers the levy and bringing milk-based drinks into scope from 2028.

But manufacturers did not reformulate by making drinks less sweet. They reformulated by replacing sugar with non-sugar sweeteners — aspartame, acesulfame-K, sucralose and, increasingly, sugar alcohols like erythritol. The government’s own consultation response noted the concern directly: dozens of health organisations warned that further sugar cuts “will probably mean further increases in the use of non-sugar sweeteners.” In other words, the healthiest-sounding drinks on the UK shelf are now sweetened almost entirely by the very compounds the 2025 headlines were about. That is the backdrop against which any “sweeteners and the brain” story needs to be read: exposure is rising, so the question of whether it matters is a real one — not just clickbait.

It also explains why this sits in the same family as our other diet-and-cognition reviews, from ultra-processed food to keto and low-carb to seed oils. Modern “brain fog” anxiety attaches itself to whatever the diet culture is arguing about — and in 2025–26, sweeteners are firmly in the frame.

The October 2025 Neurology Study — What It Actually Found

The study that lit the fuse was published in Neurology in 2025, drawing on the large Brazilian ELSA-Brasil cohort. Researchers tracked 12,772 adults (average age 52, 55% women) for around eight years, estimating intake of seven low- and no-calorie sweeteners — aspartame, saccharin, acesulfame-K, erythritol, sorbitol, xylitol and tagatose — from food-frequency questionnaires, and testing memory, language and thinking three times over the follow-up.

The finding, widely summarised by outlets including Harvard Health, was that people in the highest-intake group declined about 62% faster on overall cognition than those in the lowest group — a difference the authors likened to roughly 1.6 additional years of brain ageing. Two details drew particular attention: the association was stronger in people with diabetes, and it was detectable in participants under 60, not just the elderly. Aspartame showed the clearest signal of the individual sweeteners; tagatose was the one exception with no association.

The caveat the authors themselves stressed. This was an observational study. It can show that high sweetener intake and faster cognitive decline travel together; it cannot show that one causes the other. As the researchers put it plainly, the work “does not prove that artificial sweeteners cause cognitive decline.” That single sentence should temper every headline that dropped the word “linked.”

The Reverse-Causation Trap — and Why Diabetes Is the Tell

Here is the problem that makes nutritional epidemiology so treacherous, and it is on full display in this study. Who consumes the most artificial sweeteners? Overwhelmingly, people who are trying to manage weight, people with prediabetes or type 2 diabetes, and people already eating a heavily processed diet. Every one of those groups is independently at higher risk of cognitive decline — because of the underlying metabolic disease, not the sweetener in their drink.

That is why the finding that the effect was strongest in people with diabetes cuts both ways. Believers read it as a dose-response clue that sweeteners are harmful. Sceptics read it as a flashing warning of confounding by indication: the people consuming the most sweeteners are the people whose brains were already most at risk. It is the classic “diet-soda drinker” paradox — the drink is a marker of an unhealthy metabolic situation more than a plausible cause of it. The study adjusted for many factors, but no observational study can fully remove this, and the authors were careful not to claim they had.

None of this means the signal is nothing. It means the honest interpretation is modest: heavy sweetener intake is a reasonable thing to cut down, both because it tends to travel with a poor overall diet and because the precautionary case is growing — but the leap from “associated with” to “causes brain fog” is exactly the leap the data do not support.

Could a Sweetener Actually Fog the Brain? The Aspartame Mechanism

Association aside, is there a biologically plausible route by which a sweetener could affect cognition? For aspartame, the honest answer is: yes, on paper, at high doses, mostly in animals. Aspartame is metabolised into three components — aspartic acid, phenylalanine and a small amount of methanol. Each has a theoretical brain angle. Aspartic acid is an excitatory amino acid; elevated phenylalanine can compete with other amino acids for transport into the brain and shift neurotransmitter synthesis (the reason people with the genetic condition PKU must avoid it); and methanol is a metabolic toxin at sufficient exposure.

A 2024 review in Immunobiology pulled the mechanistic threads together, proposing that long-term aspartame exposure can push microglia — the brain’s resident immune cells — from their resting “ramified” state into a chronically activated, pro-inflammatory phenotype, releasing inflammatory mediators that damage neurons and impair cognition. Supporting animal data include a 2024 mouse study in which aspartame disrupted circadian behaviour and caused memory impairment, with disordered hippocampal neurotransmitter metabolism and inhibition of the BDNF/TrkB pathway — the same synaptic-plasticity axis that recurs throughout this blog.

This is where the story becomes interesting for our purposes, because neuroinflammation and suppressed BDNF are precisely the mechanisms Dihexa is marketed to counter. But read the caveat carefully: these are high-dose animal studies. Robust human evidence that ordinary aspartame intake — a can or two of diet drink — drives microglial neuroinflammation and fogs a healthy brain simply does not exist. The mechanism is a hypothesis with rodent support, not a demonstrated human harm. That distinction is the entire ballgame, and it is the same distinction that undoes the case for the peptide, as we will see.

Erythritol, Blood Vessels & the 2025 Stroke Signal

If aspartame is the old villain, erythritol is the new one — and here the 2025 news was genuinely striking. Erythritol is a sugar alcohol marketed as “natural” and near-zero-calorie, found in many keto and “diet” products and often the bulk ingredient in stevia and monk-fruit blends. In work from the University of Colorado Boulder, published in the Journal of Applied Physiology, researchers exposed human cerebral microvascular endothelial cells — the cells lining the brain’s small blood vessels and forming the blood-brain barrier — to the amount of erythritol in a single sweetened drink (about 30 g), for three hours.

The treated cells produced significantly less nitric oxide (which relaxes and widens vessels) and more endothelin-1 (which constricts them), raised reactive oxygen species by roughly 75%, and, when challenged with a clot-forming stimulus, released far less of the natural clot-busting compound t-PA. Taken together, that is a profile of vessel constriction, oxidative stress and impaired clot-clearance — a combination the authors linked to increased stroke risk. It follows earlier findings connecting circulating erythritol to cardiovascular events, and it is why erythritol has drawn the sharpest 2025 caution of any sweetener.

Keep the scale honest. This was a cell-culture study — brain-vessel cells in a dish, not people drinking erythritol. It does not prove erythritol causes strokes or brain fog in humans, and one experiment never should. But it is a legitimate, specific, mechanistic red flag for a sweetener many people assume is inert — and a good reason to treat “natural, zero-calorie” marketing with the same scepticism as everything else. That is the opposite lesson from “so take a peptide.”

What the Regulators Say: WHO, IARC and the 40 mg/kg Line

Set against the scary headlines is a large, boring body of regulatory assessment. In 2023 two things happened on the same day. The WHO’s cancer agency, IARC, classified aspartame as “possibly carcinogenic to humans” (Group 2B) on the basis of limited evidence — the same hazard category as aloe vera extract and pickled vegetables. Crucially, IARC assesses hazard (whether something could conceivably cause harm in some scenario), not risk at real-world doses. On the same day, the joint FAO/WHO expert committee (JECFA) reviewed the risk and reaffirmed the acceptable daily intake of 40 mg per kg of body weight — which for a 70 kg adult works out at roughly a dozen or more cans of diet drink every day, for life.

Separately, in May 2023 the WHO advised against using non-sugar sweeteners for weight control, concluding they do not help long-term weight loss and may be associated with other risks. That is an important nuance: the mainstream position is not “sweeteners are poison,” it is “don’t rely on them as a health strategy.” For the brain specifically, no regulator currently concludes that ordinary sweetener intake causes cognitive decline. The defensible reading of all of this is precautionary moderation, not fear — and certainly not a reason to escalate to an experimental drug.

Aspartame Sensitivity, Headaches & the Migraine Overlap

One genuine, if under-explained, phenomenon deserves its own mention: a minority of people report headaches, foggy-headedness or migraine after aspartame. Aspartame has long featured on lists of possible dietary migraine triggers, and for those individuals the “diet-drink brain fog” they describe may be real and personal even if population studies are equivocal. The mechanism may relate to phenylalanine’s effect on neurotransmitters, or simply to individual sensitivity that group averages wash out.

The practical point is empowering rather than alarming: if you suspect a specific sweetener affects you, you can run a clean, free n-of-1 experiment — remove it for two to three weeks, then see whether symptoms return if you reintroduce it. That single test is worth more than any biohacking purchase. It is also worth remembering that most caffeinated diet drinks bundle a caffeine crash and withdrawal in with the sweetener, and dehydration and poor sleep with it — so the fog blamed on aspartame is frequently something else entirely.

Where Dihexa Enters — and Why It Does Not Belong Here

Dihexa (PNB-0408) is a small peptide derived from angiotensin IV, developed as a positive modulator of the HGF/c-Met pathway. Hepatocyte growth factor (HGF), acting on its c-Met receptor, drives synaptogenesis — the building of new synaptic connections — and MET signalling remains active in the adult hippocampus and prefrontal cortex. In the foundational Benoist 2014 JPET study, Dihexa improved learning in rodents in an HGF/Met-dependent way. On paper, a peptide that boosts synaptogenesis and BDNF-adjacent plasticity looks like a plausible counter to sweetener-driven neuroinflammation. The mechanism of action page covers the biology in depth.

But look at what this review has established. The human evidence that sweeteners fog a healthy brain is an association at best, heavily shadowed by reverse causation. The brain-harm mechanism is high-dose animal biology. And even if you granted that sweeteners were a problem, the fix is free and obvious: drink less of them. Against that, Dihexa asks you to accept a much larger claim — that an unlicensed peptide clears the fog — on no completed human efficacy data at all. There is no published human trial of Dihexa for brain fog of any cause.

The irony that should end the discussion. Dihexa’s mechanism amplifies the pro-proliferative c-Met pathway — the same signalling that is over-active in many cancers, an oncologically relevant concern flagged repeatedly on this site. So the proposal on the table is to counter a sweetener that a cancer agency has classified as a possible carcinogen (aspartame, IARC Group 2B) by taking a research chemical that activates a cancer-associated growth pathway. If you are worried enough about aspartame’s theoretical cancer hazard to change your diet, you should be far more worried about deliberately switching on c-Met. The two concerns do not cancel; they compound.

The Fosgonimeton Parallel: a Warning From the Clinic

The Dihexa mechanism is not just untested in humans — the one time a closely related mechanism was tested rigorously, it fell short. Fosgonimeton (ATH-1017), developed by Athira Pharma, is a small-molecule positive modulator of the HGF/MET system — conceptually the same lever Dihexa pulls. It was taken into a Phase 3 Alzheimer’s trial, LIFT-AD, and it missed its primary endpoint. A purpose-built, professionally manufactured HGF/MET modulator, tested properly, failed to deliver the hoped-for cognitive benefit.

Hold that against the sweetener evidence and the asymmetry is glaring. The case that sweeteners harm cognition is an observational association the study’s own authors decline to call causal; the drug built on Dihexa’s exact pathway failed its pivotal human trial; and Dihexa itself has never completed one. When the “treatment” you are considering has weaker evidence than the “disease” you are treating, the sensible move is to do neither — and simply change what is in your glass.

What Actually Works for “Sweetener Brain Fog”

Pulling the evidence together, the practical playbook is refreshingly cheap — and, as ever on this site, that is a feature, not a bug:

  • Run the free test first. Cut diet drinks and “zero-sugar” products for two to three weeks and make water your default. If the fog lifts, you have your answer — at no cost and no risk.
  • Look at the whole drink, not just the sweetener. Many diet colas and energy drinks carry a caffeine crash and withdrawal; dehydration and poor sleep often masquerade as “aspartame fog.”
  • Treat the diet pattern, not one molecule. Heavy sweetener use usually rides along with an ultra-processed diet; improving the pattern helps the brain far more than swapping one sweetener for another.
  • Be a little more wary of erythritol. Given the 2025 vascular data, there is a reasonable case to moderate erythritol-heavy “natural” sweeteners while the research matures.
  • Mind your metabolic health. If you have diabetes or prediabetes, the cognitive risk driving the headlines is largely the metabolic disease — so managing blood sugar with your GP matters more than the sweetener choice.
  • Rule out a medical cause of persistent fog. Ongoing fog can flag thyroid disease, deficiencies, menopause, depression or sleep disorders — a GP work-up beats any supplement.
  • Skip the unproven peptide. Layering an unlicensed research chemical onto a problem you can solve by pouring a drink away adds risk without evidence — the recurring lesson of the Dihexa vs nootropics comparison and the stacking guide.

Who Should Be Especially Cautious

Two cautions bear repeating. On the sweetener side, most people can consume regulated sweeteners well within the safe limits, but anyone with PKU (phenylketonuria) must avoid aspartame entirely, and those prone to migraine or with troublesome gut symptoms from sugar alcohols may do better avoiding specific sweeteners. On the Dihexa side, the peptide should be avoided altogether — and especially by anyone with a personal or family history of cancer or any proliferative condition, anyone immunosuppressed, anyone pregnant, breastfeeding or planning pregnancy, and anyone who has not first had a proper work-up for the treatable causes of brain fog. The UK legal status page sets out why it cannot lawfully be sold to treat or enhance cognition in the first place.

The Bottom Line

“Artificial sweetener brain fog” is a real 2025–26 story built on a real but limited signal. An observational study links high sweetener intake to faster cognitive decline; a plausible high-dose animal mechanism exists; and erythritol has earned specific vascular caution. But the human evidence is shadowed by reverse causation, the regulators still judge normal intake safe, and — decisively — the fix costs nothing: drink less, drink water, fix the wider diet, and treat any underlying metabolic or medical cause. Against a problem that dissolves with tap water, an unlicensed peptide with no human efficacy data, a pro-proliferative c-Met flag, and a closest clinical relative that failed its Alzheimer’s Phase 3 is not a serious option. As always on this site, the unglamorous, well-studied path wins and the research chemical comes last.

Frequently Asked Questions

Do artificial sweeteners cause brain fog?

There is a signal, but no proof. An October 2025 Neurology study of 12,772 adults found the highest sweetener consumers declined about 62% faster on memory and thinking — but it shows association, not causation, and reverse causation is very plausible because people with metabolic disease consume more sweeteners. Worth cutting down; not a proven cause; certainly not a reason for a peptide.

Is aspartame bad for your brain?

At normal intakes, regulators judge it safe: the acceptable daily intake is 40 mg/kg/day (dozens of cans daily). IARC calls it a possible carcinogen (Group 2B) on limited evidence. High-dose animal work links it to microglial neuroinflammation and lower BDNF, but robust human evidence of harm from ordinary intake does not exist. Moderation is sensible; alarm is not.

Why do I get brain fog after drinking diet soda?

Usually it is not the sweetener directly. Suspect the caffeine crash or withdrawal, dehydration, poor sleep, or an ultra-processed diet overall. A minority are genuinely sensitive to aspartame and get headaches or fog. The free test: switch to water for two to three weeks and see if it lifts — that tells you more than any supplement.

Is erythritol safe for the brain?

Generally regarded as safe as an additive, but a 2025 University of Colorado study found one drink’s worth harmed human brain blood-vessel cells — less nitric oxide, more constriction, ~75% more reactive oxygen species and blunted clot-busting — a possible stroke concern. It was a cell study, not proof of harm in people, but a fair reason for caution.

Should I take Dihexa for artificial sweetener brain fog?

No. If sweeteners are the problem, the fix is free: drink less and switch to water. Dihexa is an unlicensed research chemical with no completed human trials for brain fog and a pro-proliferative c-Met concern. There is a particular irony in using a c-Met-activating peptide to counter a sweetener flagged as a possible carcinogen — the risks compound rather than cancel.

Are artificial sweeteners still better than sugar?

For teeth and blood-sugar spikes, they avoid some of sugar’s harms — the basis of the UK sugar-tax reformulation. But in 2023 the WHO advised against non-sugar sweeteners for weight control. The best move for the brain is not “sugar vs sweetener” but reducing very sweet ultra-processed drinks altogether and defaulting to water.

External Authoritative Sources Cited

Editorial statement: This article is part of a rolling 2026 clinical-context review series examining where Dihexa sits in the evidence hierarchy for specific concerns. We are not clinicians, and we do not sell Dihexa, supplements, drinks or diet products. This page is for education and is not medical advice. See the About page for our editorial approach and the disclaimer for legal scope. If brain fog is affecting your daily life, please speak to your GP.